| Literature DB >> 33520620 |
Ibrahim M Hezam1,2, Moddassir Khan Nayeem3, Abdelaziz Foul1, Adel Fahad Alrasheedi1.
Abstract
Since the outbreak of COVID-19, most of the countries around the world have been confronting the loss of lives, struggling with several economical parameters, i.e. low GDP growth, increasing unemployment rate, and others. It's been 11 months since we are struggling with COVID-19 and some of the countries already facing the second wave of COVID-19. To get rid of these problems, inventions of a vaccine and its optimum distribution is a key factor. Many companies are trying to find a vaccine, but for nearly 8 billion people it would be impossible to find a vaccine. Thus, the competition arises, and this competition would be too intense to satisfy all the people of a country with the vaccine. Therefore, at first, governments must identify priority groups for allocating COVID-19 vaccine doses. In this work, we identify four main criteria and fifteen sub-criteria based on age, health status, a woman's status, and the kind of job. The main and sub-criteria will be evaluated using a neutrosophic Analytic Hierarchy Process (AHP). Then, the COVID-19 vaccine alternatives will be ranked using a neutrosophic TOPSIS method. All the results obtained indicate that the healthcare personnel, people with high-risk health, elderly people, essential workers, pregnant and lactating mothers are the most prioritized people to take the vaccine dose first. Also, the results indicate that the most appropriate vaccine for patients and health workers have priority over other alternative vaccines.Entities:
Keywords: Analytic hierarchy process; COVID-19 vaccines; MCDM; Neutrosophic; TOPSIS
Year: 2020 PMID: 33520620 PMCID: PMC7832528 DOI: 10.1016/j.rinp.2020.103654
Source DB: PubMed Journal: Results Phys ISSN: 2211-3797 Impact factor: 4.476
Random Index by Saaty [4].
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0.58 | 0.90 | 1.12 | 1.24 | 1.32 | 1.41 | 1.45 | 1.49 |
Main criteria and sub-criteria descriptions.
| This group refers to the old people where their age is more than 60 years and they have some health problems. |
| It indicates to the elderly but in good health. |
| This category refers to the age group between 18 to less than 60. Besides, it is assumed that they suffer from health problems such as lack of immunity, diabetes, pressure, and other diseases that may cause death if a person is infected with COVID-19. |
| It refers to young people in good health condition. |
| The age of this group is less than 18 years, moreover, the kids suffer from health problems. |
| It indicates to the kids in good health |
| It refers to individuals who have serious diseases related to immune deficiency, diabetes, allergies, kidney failure, heart, and other very serious diseases that lead to death, especially if infection coincides with COVID-19 infection. This group with medical conditions is more likely to contract a severe COVID-19 virus, so they are classified as an independent group. |
| It refers to the individuals having health problems but not serious diseases. |
| It indicates the individuals in good health condition. |
| During the pregnancy, the women usually have a weak immunity system and are susceptible to disease, so pregnant women have been classified as a community group that has priority to take the COVID-19 vaccine over others. |
| It points to breastfeeding women and has priority because being infected with the COVID-19 virus will have serious complications for her and her infant kid. |
| It refers to other women who are not pregnant or breastfeeding. |
| All individuals working in health care places who have direct or indirect exposure to patients or infectious materials as well as people who are not directly involved in patient care but who may be exposed to infectious agents while working in a health care environment, Such as doctors, nurses, lab technicians, and administrative staff. Health workers are the first line of defense to fight the COVID-19 virus. And preserving their lives have priority so that they can continue to provide their medical services. Therefore, they were classified as an independent group. |
| This class is so important for the life continuity and maintenance of basic services, such as workers in logistics, supply, agriculture, transport, education, hygiene, energy, security, armed forces, and the judiciary. But priority should be given to those who cannot work remotely more than others. |
| It indicates to the workers in the other sectors. |
Fig. 1Main criteria, and sub-criteria used in this study.
Fig. 2Main groups overlapping.
Linguistic variables used for weighting the main criteria and sub-criteria.
| Low priority (LP) | |
| Simple Priority (SP) | |
| Medium priority (MP) | |
| High priority (HP) | |
| Extremely priority (EP) |
Evaluation of main criteria by three experts using linguistic variables.
| ــ | 1/ SP | MP | 1/LP | |
| SP | ــ | MP | 1/LP | |
| 1/MP | 1/MP | ــ | 1/MP | |
| LP | LP | MP | ــ | |
| ــ | 1/LP | SP | 1/LP | |
| LP | ــ | SP | 1 | |
| 1/SP | 1/SP | ــ | 1/LP | |
| LP | 1 | LP | ــ | |
| ــ | 1/LP | LP | 1/SP | |
| LP | ــ | MP | LP | |
| 1/LP | 1/MP | ــ | 1/SP | |
| SP | 1/LP | SP | ــ | |
Evaluation of the sub-criteria of age index by three experts using linguistic variables.
| 1 | MP | LP | EP | LP | EP | |
| 1/ MP | 1 | 1/MP | MP | 1/HP | HP | |
| 1/LP | MP | 1 | HP | 1/SP | HP | |
| 1/EP | 1/MP | 1/HP | 1 | 1/EP | 1 | |
| 1/LP | 1/HP | SP | EP | 1 | HP | |
| 1/EP | 1/HP | 1/HP | 1 | 1/HP | 1 | |
Evaluation of the sub-criteria of health state index by three experts using linguistic variables.
| 1 | HP | EP | |
| 1/ HP | 1 | HP | |
| 1/EP | 1/HP | 1 | |
Evaluation of the sub-criteria of women states index by three experts using linguistic variables.
| 1 | MP | EP | |
| 1/MP | 1 | HP | |
| 1/EP | 1/HP | 1 | |
Evaluation of the sub-criteria of job kind index by three experts using linguistic variables.
| 1 | MP | EP | |
| 1/MP | HP | ||
| 1/EP | 1/HP | 1 | |
Evaluation matrix of COVID-19 vaccine alternatives according to sub-criteria.
| w | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| A1 | EP | EP | SP | SP | LP | LP | SP | SP | SP | SP | SP | SP | SP | SP | SP |
| A2 | HP | LP | HP | LP | HP | LP | HP | MP | LP | SP | SP | SP | SP | SP | SP |
| A3 | LP | LP | LP | LP | LP | LP | LP | LP | LP | EP | EP | SP | LP | LP | LP |
| A4 | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | EP | MP | LP |
| A5 | LP | LP | MP | MP | LP | LP | LP | LP | LP | SP | SP | LP | SP | SP | SP |
| A6 | LP | LP | LP | LP | EP | EP | LP | LP | LP | LP | LP | LP | LP | LP | LP |
| w | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| A1 | HP | HP | SP | SP | LP | LP | SP | SP | SP | SP | SP | SP | SP | SP | SP |
| A2 | MP | LP | MP | LP | MP | LP | MP | SP | LP | SP | SP | SP | SP | SP | SP |
| A3 | LP | LP | LP | LP | LP | LP | LP | LP | LP | HP | HP | SP | SP | SP | SP |
| A4 | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | HP | HP | LP |
| A5 | LP | LP | HP | HP | LP | LP | LP | LP | LP | SP | SP | LP | SP | SP | SP |
| A6 | LP | LP | LP | LP | HP | HP | LP | LP | LP | LP | LP | LP | LP | LP | LP |
| w | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| A1 | MP | MP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP |
| A2 | EP | SP | EP | LP | EP | LP | EP | HP | LP | SP | SP | SP | SP | SP | SP |
| A3 | LP | LP | LP | LP | LP | LP | LP | LP | LP | MP | MP | SP | SP | SP | SP |
| A4 | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | LP | MP | MP | LP |
| A5 | LP | LP | EP | LP | EP | LP | LP | LP | LP | LP | LP | LP | LP | LP | SP |
| A6 | LP | LP | LP | LP | MP | MP | LP | LP | LP | LP | LP | LP | LP | LP | LP |
Evaluation of main criteria by three experts using neutrosophic scale.
| 1 | ||||
| 1 | ||||
| 1 | ||||
| 1 | ||||
| 1 | ||||
| 1 | 1 | |||
| 1 | ||||
| 1 | 1 | |||
| 1 | ||||
| 1 | ||||
| 1 | ||||
| 1 | ||||
Evaluation of the sub-criteria of age state index by three experts using neutrosophic scale.
| 1 | ||||||
| 1 | ||||||
| 1 | ||||||
| 1 | 1 | |||||
| 1 | ||||||
| 1 | 1 | |||||
Evaluation of the sub-criteria of health state index by three experts using neutrosophic scale.
| 1 | |||
| 1 | |||
| 1 | |||
Evaluation of the sub-criteria of women state index by three experts using neutrosophic scale.
| 1 | |||
| 1 | |||
| 1 | |||
Evaluation of the sub-criteria of job kind state index by three experts using neutrosophic scale.
| 1 | |||
| 1 | |||
De-neutrosophiction for evaluation of main criteria by three experts.
| 1 | 0.3419 | 4.8750 | 0.9877 | |
| 2.9250 | 1 | 4.8750 | 0.9877 | |
| 0.2051 | 0.2051 | 1 | 0.2051 | |
| 1.0125 | 1.0125 | 4.8750 | 1 | |
| 1 | 0.9877 | 2.9250 | 0.9877 | |
| 1.0125 | 1 | 2.9250 | 1 | |
| 0.3419 | 0.3419 | 1 | 0.9877 | |
| 1.0125 | 1 | 1.0125 | 1 | |
| 1 | 0.9877 | 1.0125 | 0.3419 | |
| 1.0125 | 1 | 4.8750 | 1.0125 | |
| 0.9877 | 0.2051 | 1 | 0.3419 | |
| 2.9250 | 0.9877 | 2.9250 | 1 | |
De-neutrosophication the sub-criteria of age state index by three experts.
| 1 | 4.8750 | 1.0125 | 9.4500 | 1.0125 | 9.4500 | |
| 0.2051 | 1 | 0.2051 | 4.8750 | 0.1411 | 7.0875 | |
| 0.9877 | 4.8750 | 1 | 7.0875 | 0.3419 | 7.0875 | |
| 0.1058 | 0.2051 | 0.1411 | 1 | 0.1058 | 1 | |
| 0.9877 | 0.1411 | 2.9250 | 9.4500 | 1 | 7.0875 | |
| 0.1058 | 0.1411 | 0.1411 | 1 | 0.1411 | 1 | |
De-neutrosophication the sub-criteria of health state index by three experts.
| 1 | 7.0875 | 9.4500 | |
| 0.1411 | 1 | 7.0875 | |
| 0.1058 | 0.1411 | 1 | |
De-neutrosophication the sub-criteria of women state index by three experts.
| 1 | 4.8750 | 9.4500 | |
| 0.2051 | 1 | 7.0875 | |
| 0.1058 | 0.1411 | 1 | |
De-neutrosophication the sub-criteria of job state index by three experts.
| 1 | 4.8750 | 9.4500 | |
| 0.2051 | 1 | 7.0875 | |
| 0.1058 | 0.1411 | 1 | |
Final weights of main criteria by three experts.
| 0.9506 | 0.2376 | 1.2141 | 0.3035 | 0.7093 | 0.1773 | 0.2395 | 3 | |
| 1.5820 | 0.3955 | 1.2246 | 0.3062 | 1.3576 | 0.3394 | 0.3470 | 1 | |
| 0.2485 | 0.0621 | 0.5799 | 0.1450 | 0.4599 | 0.1150 | 0.1074 | 4 | |
| 1.2189 | 0.3047 | 0.9814 | 0.2453 | 1.4732 | 0.3683 | 0.3061 | 2 |
Fig. 3Ranking of experts for the main criteria.
Fig. 4Ranking of main criteria by three experts.
Fig. 5Final weights of main criteria.
Local weights, global weights, and ranking of sub-indices.
| Sub-indices | |||||||||||||||
| Local weights | 0.3102 | 0.1006 | 0.2444 | 0.0292 | 0.2853 | 0.0304 | 0.7341 | 0.2129 | 0.0530 | 0.7040 | 0.2423 | 0.0537 | 0.7040 | 0.2423 | 0.0537 |
| Global weights | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| Local rank | 1 | 4 | 3 | 6 | 2 | 5 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| Global rank | 4 | 10 | 8 | 14 | 7 | 13 | 1 | 6 | 11 | 3 | 9 | 15 | 2 | 5 | 12 |
Fig. 6Final weights of sub-criteria.
Ranking of alternatives by TOPSIS method.
| 0.2149 | 0.0759 | 0.2610 | 3 | |
| 0.1162 | 0.2245 | 0.6589 | 1 | |
| 0.2517 | 0.0671 | 0.2105 | 4 | |
| 0.2265 | 0.1578 | 0.4106 | 2 | |
| 0.2515 | 0.0531 | 0.1743 | 5 | |
| 0.2734 | 0.0387 | 0.1240 | 6 |
De-neutrosophication the evaluation matrix of COVID-19 vaccine alternatives according to sub- criteria.
| w | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| A1 | 9.4500 | 9.4500 | 2.9250 | 2.9250 | 1.0125 | 1.0125 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A2 | 7.0875 | 1.0125 | 7.0875 | 1.0125 | 7.0875 | 1.0125 | 7.0875 | 4.8750 | 1.0125 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A3 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 9.4500 | 9.4500 | 2.9250 | 1.0125 | 1.0125 | 1.0125 |
| A4 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 9.4500 | 4.8750 | 1.0125 |
| A5 | 1.0125 | 1.0125 | 4.8750 | 4.8750 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 2.9250 | 2.9250 | 1.0125 | 2.9250 | 2.9250 | 2.9250 |
| A6 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 9.4500 | 9.4500 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 |
| w | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| A1 | 7.0875 | 7.0875 | 2.9250 | 2.9250 | 1.0125 | 1.0125 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A2 | 4.8750 | 1.0125 | 4.8750 | 1.0125 | 4.8750 | 1.0125 | 4.8750 | 2.9250 | 1.0125 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A3 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 7.0875 | 7.0875 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A4 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 7.0875 | 7.0875 | 1.0125 |
| A5 | 1.0125 | 1.0125 | 7.0875 | 7.0875 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 2.9250 | 2.9250 | 1.0125 | 2.9250 | 2.9250 | 2.9250 |
| A6 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 7.0875 | 7.0875 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 |
| w | 0.0743 | 0.0241 | 0.0585 | 0.0070 | 0.0683 | 0.0073 | 0.2547 | 0.0739 | 0.0184 | 0.0756 | 0.0260 | 0.0058 | 0.2155 | 0.0742 | 0.0164 |
| A1 | 4.8750 | 4.8750 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 |
| A2 | 9.4500 | 2.9250 | 9.4500 | 1.0125 | 9.4500 | 1.0125 | 9.4500 | 7.0875 | 1.0125 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A3 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 4.8750 | 4.8750 | 2.9250 | 2.9250 | 2.9250 | 2.9250 |
| A4 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 4.8750 | 4.8750 | 1.0125 |
| A5 | 1.0125 | 1.0125 | 9.4500 | 1.0125 | 9.4500 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 2.9250 |
| A6 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 4.8750 | 4.8750 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 | 1.0125 |
Fig. 7Final ranking of COVID-19 vaccine alternatives by TOPSIS method.
| Phase 1: the experts’ phase |
Collect the essential date. |
Identify the main criteria, sub-criteria, and COVID-19 vaccines alternatives. |
Evaluate the main criteria, sub-criteria, and COVID-19 vaccines alternatives. |
Confirm the evaluation of the main criteria, sub-criteria, and alternatives. |
Construct the hierarchy structure |
| Phase 2: Criteria evaluation (Neutrosophic-AHP) |
Experts’ construct a pairwise comparison. |
Deneutrosophication the neutrosophic numbers to real value using Eq. |
Normalize the evaluation matrix. |
Check comparison consistency using Eq. |
Find the weights. |
| Phase 3: Ranking alternatives (Neutrosophic-TOPSIS) |
Construct an evaluation matrix between the sub-criteria and alternatives by three experts. |
Deneutrosophication the neutrosophic numbers to real value using Eq. |
Normalize the evaluation matrix. |
Determine the positive ideal solution and the negative ideal solution (PIS, NIS) using Eqs. |
Rank alternatives according to the relative coefficient using Eq. |
Keep the superlative alternative |
| Phase 4: Recommendations |
Recommend the priority of groups and the superior alternative. |